Home Cart Sign in  
Chemical Structure| 479080-38-1 Chemical Structure| 479080-38-1

Structure of OT antagonist 1
CAS No.: 479080-38-1

Chemical Structure| 479080-38-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

OT antagonist 1 (Compound 4) is a potent, selective Oxytocin antagonist with a Ki of 50 nM.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of OT antagonist 1

CAS No. :479080-38-1
Formula : C22H22N4O3
M.W : 390.44
SMILES Code : CC1=NOC([C@@H](N(C(C2=CC=C(C3=CC=CC=C3C)C=C2)=O)C/4)CC4=N/OC)=N1
MDL No. :N/A

Safety of OT antagonist 1

Related Pathways of OT antagonist 1

GPCR

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01839253 Orthognathic Surgery Not Applicable Completed - Korea, Republic of ... More >> Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine Seoul, Korea, Republic of, 120-752 Less <<
NCT01778049 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00857012 - Completed - -
NCT00666458 Type 2 Diabetes Phase 3 Completed - -
NCT01778049 - Completed - -
NCT02188550 Ovarian Cancer ... More >> Endometrial Cancer Less << Phase 2 Unknown - United States, Maryland ... More >> Sinai Hospital of Baltimore, Inc. Recruiting Baltimore, Maryland, United States, 21215 Contact: Judy Bosley, BSN, RN    410-601-6120    jbosley@lifebridgehealth.org    Contact: Melissa Loomis    410-601-6120    mloomis@lifebridgehealth.org    Principal Investigator: Kenneth Miller, M.D. Less <<
NCT00666458 - Completed - -
NCT03481257 - Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Gyeonggi-do, Korea, Republic of, 463707 Less <<
NCT01638988 Polycystic Ovary Syndrome ... More >> Insulin Resistance Less << Phase 3 Withdrawn(Previous studies hav... More >>e been done regarding same condition) Less << December 2015 Canada, Quebec ... More >> Clinique Ovo Montréal, Quebec, Canada, H4P 2S4 Less <<
NCT02389933 - - - -
NCT00776243 - Completed - Korea, Republic of ... More >> Division of Endocrinology and Metabolism, St.Vincent's Hospital Suwon, Kyonggi-do, Korea, Republic of, 442-723 Division of Endocrinology and Metabolism, Kangnam St.Mary's Hospital Seoul, Korea, Republic of, 137-701 Less <<
NCT00775242 Menopause Phase 2 Phase 3 Completed - Mexico ... More >> Centro A.F. de Estudios Tecnologicos, S.A. Mexico, DF, Mexico, 03100 Less <<
NCT02226120 Chronic Heart Failure With Red... More >>uced Ejection Fraction Less << Phase 3 Completed - -
NCT02260492 Asthma Phase 1 Completed - -
NCT01263353 Gastroenteropancreatic Neuroen... More >>docrine Tumor of the Pulmonary ot Gastroenteropancreatic System Less << Phase 1 Completed - Germany ... More >> Novartis Investigative Site Bad Berka, Germany, 99438 Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Marburg, Germany, 35039 Novartis Investigative Site Muenster, Germany, 48149 Less <<
NCT02465515 Diabetes Mellitus Phase 4 Completed - -
NCT00295347 Major Depression Not Applicable Completed - Germany ... More >> University Hospital Hamburg-Eppendorf Hamburg, Germany, 20246 Less <<
NCT00753168 Glaucoma, Open-Angle ... More >> Ocular Hypertension Less << Phase 1 Phase 2 Completed - United States, California ... More >> Artesia, California, United States United States, Georgia Roswell, Georgia, United States United States, North Carolina Charlotte, North Carolina, United States High Point, North Carolina, United States United States, South Carolina Mount Pleasant, South Carolina, United States Less <<
NCT02260492 - Completed - -
NCT01836263 - Unknown June 2017 France ... More >> Université Paris Descartes, Hôpital Cochin, Service de Rhumatologie A & INSERM 1016 Recruiting Paris, France, 75014 Principal Investigator: Yannick Allanore, Prof.          Germany Justus-Liebig-University Gießen, Kerckhoff Clinic, Departement of Rheumatology and Clinical Immunology Recruiting Bad Nauheim, Germany, 61231 Principal Investigator: Ulf Müller-Ladner, Prof.          Sub-Investigator: Ingo H. T, Dr.          Sub-Investigator: Marc Frerix, Dr.          Charité Universitätsmedizin Berlin, Charité Centrum 12 für Innere Medizin und Dermatologie, Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie Recruiting Berlin, Germany, 10117 Principal Investigator: Gabriela Riemekasten, Prof.          Centre for Pediatric Rheumatology, Klinikum Eilbek Recruiting Hamburg, Germany, 22081 Principal Investigator: Ivan Foeldvari, Dr.          Hungary Pecsi Tudomanyegyetem - University of Pecs Recruiting Pecs, Hungary, H-7622 Principal Investigator: Laszlo Czirjak, Prof.          Italy University of Florence, Denothe Centre, Division of Rheumatology AOUC, Department of Biomedicine Recruiting Firenze, Italy, 50139 Principal Investigator: Marco Matucci-Cerinic, Prof.          Policlinico, Via Pansini Recruiting Napoli-Italia, Italy, 5-80131 Principal Investigator: Gabriele Valentini, Prof.          Switzerland Felix-Platter Spital, University of Basel Recruiting Basel, Switzerland, CH 4012 Principal Investigator: Ulrich Walker, Prof.          University of Zurich, Department of Rheumatology Recruiting Zurich, Switzerland, 8006 Principal Investigator: Oliver Distler, Prof.          United Kingdom The Universitiy of Leeds, Division of Rheumatic and Musculoskeletal Disease, St James's University Hospital Recruiting Leeds, United Kingdom, LS9 7TF Principal Investigator: Francesco Del Galdo, Dr.          Royal Free Hospital, University College London Recruiting London, United Kingdom, NW3 2QG Principal Investigator: Christopher Denton, Prof. Less <<
NCT03062150 Major Depression Not Applicable Recruiting June 30, 2019 Germany ... More >> Charité Universitätsmedizin Berlin Recruiting Berlin, Germany, 12203 Contact: Christian Otte, Prof. Dr.    +49-30-450-517532    Christian.Otte@charite.de Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.56mL

0.51mL

0.26mL

12.81mL

2.56mL

1.28mL

25.61mL

5.12mL

2.56mL

 

Historical Records

Categories